ALK and neuroblastoma: Activating mutations in the tyrosine kinase domain of the anaplastic lymphoma kinase (ALK) oncogene are acquired hereditarily or somatically in familial and sporadic NB cases, respectively, and account for disease susceptibility as well as disease progression [9–12].